Author(s):
Diana Ali Alkhalil, Moofeed Yasein
Email(s):
dianaalialkhalil@gmail.com , moufidy@tishreen.edu.sy
DOI:
10.52711/0974-360X.2021.00421 
Address:
~2
1Master Student in Analytical and Food Chemistry Department, Faculty of Pharmacy, Tishreen University, Lattakia, Syria.
2Prof. Dr. in Analytical and Food Chemistry Department, Faculty of Pharmacy, Tishreen University, Lattakia, Syria.
*Corresponding Author
Published In:
Volume - 14,
Issue - 5,
Year - 2021
ABSTRACT:
No-caloric sweeteners, such as aspartame, are widely used in various food and beverages to prevent the increasing rates of obesity and diabetes mellitus, acting as tools in helping control caloric intake. Aspartame is a methyl ester of a dipeptide used as a synthetic nonnutritive sweetener in over 90 countries worldwide in over 6000 products. It was first approved by the US Food and Drug Administration (FDA) in 1981. Aspartame is metabolized to phenylalanine, aspartic acid, and methanol. these metabolites have some health risks specially on PKU (Phenyl Ketone Urea) patients who can’t metabolize the amino acid phenyl alanine. This study aims to investigate the health effects of aspartame on Balb-c mice. 16 Balb-c mice were given physiological solution by oral gavage(control) and the study groups were given the recommended ADI (Acceptable Daily Intake) for mice (ADI = 250mg/kg/body weight) of Aspartame diluted in water for 15days, 30days. Glucose blood level, lipid profile, marker enzymes (ALT.AST.ALP, ?GT) and uric acid were determined at the end of the experiment. The results of this study show that oral administration of aspartame (250mg/kg body weight) was correlated to a significant increase in the lipid profile, fasting blood glucose and some marker enzymes and this increase is time related.
Cite this article:
Diana Ali Alkhalil, Moofeed Yasein. Investigation of Aspartame effects on some blood parameters after oral administration in Balb-c mice. Research Journal of Pharmacy and Technology. 2021; 14(5):2387-0. doi: 10.52711/0974-360X.2021.00421
Cite(Electronic):
Diana Ali Alkhalil, Moofeed Yasein. Investigation of Aspartame effects on some blood parameters after oral administration in Balb-c mice. Research Journal of Pharmacy and Technology. 2021; 14(5):2387-0. doi: 10.52711/0974-360X.2021.00421 Available on: https://www.rjptonline.org/AbstractView.aspx?PID=2021-14-5-5
REFERENCES:
1. Otman, S. and M. Bin-Jumah, Histopathological Effect of Aspartame on Liver and Kidney of Mice. International Journal of Pharmacology, 2019. 15(3): p. 336-342.
2. Nofre, C. and J.-M. Tinti, Neotame: discovery, properties, utility. Food Chemistry, 2000. 69(3): p. 245-257.
3. Butchko, H.H. and W.W. Stargel, Aspartame: scientific evaluation in the postmarketing period. Regulatory Toxicology and Pharmacology, 2001. 34(3): p. 221-233.
4. Mazur, R.H., Discovery of aspartame. Aspartame Physiology and Biochemistry (Stegink LD, Filer LJ Jr, eds). New York: Dekker, 1984: p. 3-9.
5. Vijayabhaskar, K., et al., Antioxidant and Hepatoprotective Effects of the Methanol Extract of the Flowers of Tamarindus indica. Asian Journal of Pharmacy and Technology, 2011. 1(3): p. 73-78.
6. Magnuson, B., et al., Aspartame: a safety evaluation based on current use levels, regulations, and toxicological and epidemiological studies. Critical Reviews in Toxicology, 2007. 37(8): p. 629-727.
7. Goerss, A.L., G.C. Wagner, and W.L. Hill, Acute effects of aspartame on aggression and neurochemistry of rats. Life Sciences, 2000. 67(11): p. 1325-1329.
8. Davoli, E., et al., Serum methanol concentrations in rats and in men after a single dose of aspartame. Food and Chemical Toxicology, 1986. 24(3): p. 187-189.
9. Pradhan, R. and A. Ray, Effect of Light/Dark Cycle on Amino Acids and Protein in the muscle of Chicken. Interaction, 2011. 4(0049): p. 3.
10. Scriver, C.R., The hyperphenylalaninemias. The metabolic and Molecular Bases of Inherited Disease, 1995.
11. Groff, J.L. and S.A.S. Gropper, Advanced nutrition and human metabolism. 2000: Wadsworth Publishing Company.
12. Saha, D. and S. Paul, Cytotoxic Activity of Methanolic Extract of Alpinia conchigera Griff (Family: Zingiberaceae). Asian Journal of Pharmaceutical Research, 2012. 2(2): p. 86-88.
13. Opperman, J., Aspartame metabolism in animals. Aspartame Physiology and Biochemistry (Stegink LD, Filer LJ Jr, eds). New York: Dekker, 1984: p. 141-159.
14. Parthasarathy, N.J., et al., Methanol-induced oxidative stress in rat lymphoid organs. Journal of occupational health, 2006. 48(1): p. 20-27.
15. Ikewuchi Jude, C., et al., Moderation of the Plasma Chemistry and Hematological Indices of Normal and Salt-loaded Rats by an Aqueous Extract of the Rhizomes of Sansevieria Liberica: Implications for the Management of Hypertension and Associated Complications. 2013.
16. Yakubu, M., et al., Effect of repeated administration of sildenafil citrate on selected enzyme activities of liver and kidney of male albino rats. Nig J Pure and Appl Sci, 2003. 18: p. 1395-400.
17. Renwick, A. and H. Nordmann, First European conference on aspartame: Putting safety and benefits into perspective. Synopsis of presentations and conclusions. Food and Chemical Toxicology, 2007. 45(7): p. 1308-1313.
18. Kotsonis, F.N. and J.J. Hjelle, The safety assessment of aspartame: scientific and regulatory considerations. The clinical evaluation of a food additive assessment of aspartame. CRC Press: Boca Raton, FL, 1996: p. 23-41.
19. Poisoning, A.A.O.C.T.A.H.C.O.T.T.G.F.m., et al., American Academy of Clinical Toxicology practice guidelines on the treatment of methanol poisoning. Journal of Toxicology: Clinical Toxicology, 2002. 40(4): p. 415-446.
20. Butchko, H.H. and F.N. Kotsonis, Acceptable daily intake vs actual intake: the aspartame example. Journal of the American College of Nutrition, 1991. 10(3): p. 258-266.
21. Fernstrom, J., Oral aspartame and plasma phenylalanine: pharmacokinetic difference between rodents and man, and relevance to CNS effects of phenylalanine. Journal of Neural Transmission, 1989. 75(2): p. 159-164.
22. Sims, K.L., Clinical Diagnosis and Management by Laboratory Methods, Philadelphia, Saunders, 1996 ((USD) 82.50). Modern Pathology, 1997. 10(4): p. 311-311.
23. Sheets, A., Hitachi 704 Cholesterol. 1998, HP.
24. Bachorik, P., Collection of blood samples for lipoprotein analysis. Clinical Chemistry, 1982. 28(6): p. 1375-1378.
25. Gowda, S., et al., A review on laboratory liver function tests. The Pan African Medical Journal, 2009. 3.
26. Yu, J., et al., Microfluidic paper-based chemiluminescence biosensor for simultaneous determination of glucose and uric acid. Lab on a Chip, 2011. 11(7): p. 1286-1291.
27. Sandhiya, K., A Comparative Study to Assess The Dietary Habits of School Children with Underweight and Normal Weight in a Selected Government Higher Secondary School at Kirumampakkam, Puducherry. International Journal of Advances in Nursing Management, 2014. 2(4): p. 221-225.
28. Palmnäs, M.S., et al., Low-dose aspartame consumption differentially affects gut microbiota-host metabolic interactions in the diet-induced obese rat. PloS one, 2014. 9(10).
29. Collison, K.S., et al., Interactive effects of neonatal exposure to monosodium glutamate and aspartame on glucose homeostasis. Nutrition and Metabolism, 2012. 9(1): p. 58.
30. Thokada, S.S., A Case Report on Hepatic Encephalopathy in Chronic Liver Disease with Portal Hypertension. Asian Journal of Research in Pharmaceutical Science, 2019. 9(4): p. 270-272.
31. Alkafafy, M.E.-S., et al., Impact of aspartame and saccharin on the rat liver: Biochemical, molecular, and histological approach. International Journal of Immunopathology and Pharmacology, 2015. 28(2): p. 247-255.
32. Charlet, R.M. and R. Anuradha, Effect of protocatechuic acid on TNF-mRNA level in the liver of Hepatotoxicity rats. Research Journal of Pharmaceutical Dosage Forms and Technology, 2012. 4(6): p. 324-327.
33. Abhilash, M., et al., Effect of long term intake of aspartame on antioxidant defense status in liver. Food and Chemical Toxicology, 2011. 49(6): p. 1203-1207.
34. Saul, S., Effects of Nyctanthes Arbor-Tristis and Colchicine on the Growth of Uric Acid Crystals. Asian Journal of Pharmaceutical Analysis, 2017. 7(2): p. 84-86.
35. Alkadasi, M.N., A.M. Alshami, and H. Alhabal, Study the Relation of Serum Lipids with Body Mass Index Among Students in Zabeed Education Collage, Hudaiadah University, Yemen. Asian Journal of Pharmaceutical Analysis, 2015. 5(1): p. 31-35.
36. Von Poser Toigo, E., et al., Metabolic and feeding behavior alterations provoked by prenatal exposure to aspartame. Appetite, 2015. 87: p. 168-174.
37. Murad, S., et al., Abnormal Lipid Parameters and Herbs. Asian Journal of Pharmaceutical Research, 2019. 9(3): p. 155-158.
38. Lebda, M.A., H.G. Tohamy, and Y.S. El-Sayed, Long-term soft drink and aspartame intake induces hepatic damage via dysregulation of adipocytokines and alteration of the lipid profile and antioxidant status. Nutrition Research, 2017. 41: p. 47-55.